Influence of galectin-3 on apoptosis of eosinophils and expression of Bcl-2 protein in lung tissue of asthmatic guinea pigs
HU Zhi-xion
Abstract
HU Zhi-xion
Abstract
Objective:To study the influence of galectin-3 on apoptosis of eosinophils and Bcl-2 protein expression in lung tissue of asthmatic guinea pigs. Methods: Thirty-six guinea pigs were randomly divided into saline group, asthma group and galectin-3 group (n=12). Asthma model was created with ovalbumin (OVA). Galectin-3 (0.5 mg/kg) was injected intraperitoneally daily 1 hour before stimulation during the 15th to 21st day of sensitization in galectin-3 group. Interleukin 5 (IL-5) level and eosinophil counts in bronchoalveolar lavage fluid (BALF) were determined. Pulmonary pathological change was observed. Apoptosis of eosinophils and expression of Bcl-2 protein in lung tissue were detected by TUNEL method and immunohistochemistry, respectively. Results:Compared with asthma group, IL-5 level and eosinophil counts in BALF were significantly lower in galectin-3 group (P0.05). Furthermore, significantly milder inflammatory reaction was observed in lung tissue in galectin-3 group than that in asthma group, with higher eosinophilic apoptosis index and lower expression level of Bcl-2 protein (P0.05). Conclusion:Galectin-3 can reduce the eosinophil counts in BALF and inflammation in lung tissue of asthmatic guinea pigs via reducing IL-5 level in BALF, inhibiting Bcl-2 protein expression and promoting eosinophilic apoptosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the influence of galectin-3 on apoptosis of eosinophils and Bcl-2 protein expression in lung tissue of asthmatic guinea pigs. Methods: Thirty-six guinea pigs were randomly divided into saline group, asthma group and galectin-3 group (n=12). Asthma model was created with ovalbumin (OVA). Galectin-3 (0.5 mg/kg) was injected intraperitoneally daily 1 hour before stimulation during the 15th to 21st day of sensitization in galectin-3 group. Interleukin 5 (IL-5) level and eosinophil counts in bronchoalveolar lavage fluid (BALF) were determined. Pulmonary pathological change was observed. Apoptosis of eosinophils and expression of Bcl-2 protein in lung tissue were detected by TUNEL method and immunohistochemistry, respectively. Results:Compared with asthma group, IL-5 level and eosinophil counts in BALF were significantly lower in galectin-3 group (P0.05). Furthermore, significantly milder inflammatory reaction was observed in lung tissue in galectin-3 group than that in asthma group, with higher eosinophilic apoptosis index and lower expression level of Bcl-2 protein (P0.05). Conclusion:Galectin-3 can reduce the eosinophil counts in BALF and inflammation in lung tissue of asthmatic guinea pigs via reducing IL-5 level in BALF, inhibiting Bcl-2 protein expression and promoting eosinophilic apoptosis.
Key concepts: Ovalbumin, Eosinophil, Medicine, Bronchoalveolar lavage, Galectin, TUNEL assay, Apoptosis, Guinea pig